Benefits
Reduced upper respiratory symptoms
The one meta-analysis cited on this page pooled 4 randomized trials with 180 participants in total and concluded that elderberry supplementation substantially reduced upper respiratory symptoms. Its conclusion does not state an average 2 to 4 day reduction in illness duration. The 4-day figure traces to a single small industry-linked influenza trial in 60 patients that is not cited on this page.
Antiviral activity in laboratory studies
In laboratory studies, elderberry flavonoids bind to influenza virion surface proteins and inhibit viral entry into cultured cells, with reported activity against H1N1 and H5N1 strains. No source is cited on this page for this work, and it is laboratory activity only. It is not evidence that elderberry prevents or treats any viral infection in people.
Cytokine effects reported in laboratory studies
Laboratory studies have reported that elderberry extracts increase production of inflammatory cytokines by immune cells. This work is uncited on this page, no cited study measured cytokines in people, and nothing cited supports the claim that a pro-inflammatory effect is beneficial. This is the same mechanism behind the autoimmune caution listed under side effects, so anyone with an autoimmune condition should speak with a doctor before use.
Antioxidant capacity in laboratory assays
Elderberry anthocyanins score high in laboratory antioxidant assays. The single study cited on this page measured no oxidative stress marker, so any effect on oxidative stress or free radical damage in people is unmeasured here.
Mechanism of action
Viral hemagglutinin inhibition
Elderberry polyphenols bind to influenza hemagglutinin, the surface protein responsible for viral attachment to host cell sialic acid receptors. In laboratory studies this blocks viral entry and reduces infectivity. No study cited on this page measured viral entry or infectivity in people.
Cytokine induction
In laboratory studies, elderberry extracts have been reported to activate monocytes and macrophages to produce pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Whether this occurs at supplement doses in people was not measured by the study cited on this page, and this is the mechanism behind the autoimmune caution listed under side effects.
Neuraminidase inhibition
In laboratory assays, flavonoids from elderberry inhibit neuraminidase, the enzyme influenza virus uses to release newly formed virions from infected cells. Whether this reduces viral spread in the human respiratory tract at supplement doses was not measured in the study cited on this page.
Clinical trials
Meta-analysis of 4 randomized controlled trials pooling 180 participants in total (Hawkins et al., Complement Ther Med 2019, PMID 30670267), examining black elderberry (Sambucus nigra) supplementation for upper respiratory symptoms.
Pooled across 4 clinical trials, 180 participants in total.
Elderberry supplementation reduced upper respiratory symptom duration vs placebo, with effect more pronounced for influenza-like illness than non-influenza colds. Effect sizes meaningful but trials were generally small. Note: a major 2019 evidence review (Hawkins et al.) found pooled benefit; subsequent independent replications have been more mixed. Recent COVID-era trials of elderberry for respiratory infection prevention have been less impressive.
Randomized controlled trial of elderberry extract (Sambucol®, 15 mL four times daily) vs placebo in 60 patients with confirmed influenza A or B within 48 hours of symptom onset. (Zakay-Rones et al., J Int Med Res; this trial is not among the references cited on this page)
60 patients with confirmed influenza.
Recovery was an average of 4 days earlier in elderberry group vs placebo. Significant reductions in fever, headache, muscle aches, nasal congestion, and cough. Critical caveat: small trial (n=60), conducted by Israeli investigators with industry connection to Sambucol®. Larger independent replication has been limited. The 4-day recovery improvement is impressive but should be tempered by trial size and subsequent mixed evidence. Modern flu antivirals (oseltamivir) provide ~1-day reduction — comparable elderberry effects would be remarkable but require confirmation.